Follow The Filings

CLH Clean Harbors Inc.

Industrials, filed as CLEAN HARBORS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 2 managers in 2026 Q2

  • 3 Owners
  • Max 2.6%
  • $661M
  • 1 reduce 1 exit 2 small

In 2026 Q2 Henry Ellenbogen trimmed Clean Harbors, and Stephen Mandel sold out.

Who owns this now

Largest portfolio weights among holders, up to 2.6% (Henry Ellenbogen, Durable Capital Partners). Not free-float ownership.

  1. Henry Ellenbogen Reduce 2.6%
  2. Dan Sundheim Reduce 1.1%

Who owns CLH

Sorted by value, long equity only, as of 2026 Q2.

History
Dan Sundheim, D1 Capital Partners 1.1%, was 3.4% Small trim −1.7% 1,315,501 $393M History
Henry Ellenbogen, Durable Capital Partners 2.6%, was 3.1% Reduce −15.1% 892,405 $267M History
First Eagle Investment Management <0.01% Small add +1.5% 3,874 $1.2M History
Stephen Mandel, Lone Pine Capital exited 2026 Q2 Last 2026 Q1 4.0% Exit −4.01% 1,754,950 $503M History

3 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CLH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CLH insider trades
  • $136K bought by 1 insider
  • $63.4M sold by 9 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Eric W Gerstenberg CEO
    Sale
    $803K 2,500 shares at $321.34 4.2% of stake
    Traded Aug 14 Filed Aug 18
    ↗
  2. Eric J. Dugas CFO
    Sale
    $784K 2,788 shares at $281.31 12% of stake
    Traded Feb 20 Filed Aug 14
    ↗
  3. Eric W Gerstenberg CEO
    Sale
    $293K 1,000 shares at $293.00 1.6% of stake
    Traded Mar 18 Filed Aug 14
    ↗
  4. Eric W Gerstenberg CEO
    Sale
    $700K 2,500 shares at $279.86 3.8% of stake
    Traded Feb 23 Filed Aug 14
    ↗
  5. Andrea Robertson Director
    Sale
    $248K 789 shares at $314.01 8.1% of stake
    Traded Aug 3 Filed Aug 3
    ↗
  6. Lauren States Director
    Sale
    $226K 789 shares at $286.19 6.5% of stake
    Traded May 26 Filed May 27
    ↗
  7. Karyn Polito Director
    Buy
    $136K 460 shares at $295.13 +15% to stake
    Traded May 11 Filed May 14
    ↗
  8. Marcy L. Reed Director
    Sale
    $241K 836 shares at $287.94 14% of stake
    Traded Mar 18 Filed Mar 19
    ↗
  9. Brian P Weber EVP (chesi)
    Sale
    $1.4M 4,683 shares at $293.39 8.8% of stake
    Traded Mar 17 Filed Mar 17
    ↗
  10. Alan S McKim Chair
    Sale
    $29.3M 100,000 shares at $292.65 4.6% of stake
    Traded Mar 4 Filed Mar 5
    ↗
  11. Alan S McKim Chair
    Sale
    $28.1M 100,000 shares at $281.14 4.2% of stake
    Traded Feb 19 Filed Feb 23
    ↗
  12. Sharon M. Gabriel EVP/CIO (chesi)
    Sale
    $999K 3,540 shares at $282.07 13% of stake
    Traded Feb 20 Filed Feb 20
    ↗
  13. John R. Welch Director
    Sale
    $205K 750 shares at $273.07 6.8% of stake
    Traded Feb 19 Filed Feb 20
    ↗
  14. Eric W Gerstenberg CEO
    Sale
    $145K 601 shares at $240.90 1.2% of stake
    Traded Dec 16, 2025 Filed Dec 17, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 36 share withholdings for taxes, 29 stock grants, 9 sales back to the company, and 5 gifts.

Congress

2 members of Congress traded CLH in the last three years: 2 buys and 11 sales. 1 member listed it in 2025 annual reports.

All Congress trades
  1. April McClain Delaney D-MD-6Child Sell $50K–$100K Aug 25 filed Sep 9
  2. April McClain Delaney D-MD-6Child Partial sale $1K–$15K Jul 28 filed Aug 3
  3. April McClain Delaney D-MD-6Child Partial sale $1K–$15K Jul 27 filed Aug 3
  4. April McClain Delaney D-MD-6Child Partial sale $1K–$15K Jul 24 filed Aug 3
  5. April McClain Delaney D-MD-6Child Partial sale $1K–$15K May 1 filed Jun 5
  6. April McClain Delaney D-MD-6Child Partial sale $1K–$15K Apr 30 filed May 6

SEC filings

Recent issuer filings from EDGAR, 9 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 1.01,2.03,8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $5.41B $5.89B $6.03B
Net income $377.86M $402.3M $390.97M
Net margin * 7.0% 6.8% 6.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $2.05B $2.43B $2.65B
Total non-current assets * $4.33B $4.94B $4.98B
Total assets $6.38B $7.38B $7.62B
Total current liabilities $1.04B $1.1B $1.14B
Total non-current liabilities $3.1B $3.7B $3.74B
Total equity $2.25B $2.57B $2.75B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $734.55M $777.77M $866.72M
Cash from investing -$575.05M -$903.67M -$425.79M
Cash from financing -$208.89M $377.03M -$309.34M
Net change in cash -$47.9M $242.49M $139.12M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.